Ma; Shuli
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ma; Shuli.The latest application filed is for "anti-cd137 antibody and uses thereof".
- Ma; Shuli - Jiangsu CN
- MA; Shuli - Suzhou CN
| Patent | Date |
|---|---|
| IL-10 EGFR antibody fusion protein and uses thereof Grant 11,357,826 - Xu , et al. June 14, 2 | 2022-06-14 |
| Anti-cd137 Antibody And Uses Thereof App 20210380708 - ZHANG; Xin ; et al. | 2021-12-09 |
| Fully human antibody against human CD 137 Grant 10,875,926 - Xu , et al. December 29, 2 | 2020-12-29 |
| Anti-OX40 antibody and application thereof Grant 10,624,974 - Xu , et al. | 2020-04-21 |
| Proteinaceous Complexes and Uses Thereof App 20200069773 - XU; Ting ; et al. | 2020-03-05 |
| Proteinaceous heterodimer and use thereof Grant 10,471,124 - Xu , et al. Nov | 2019-11-12 |
| Fully Human Antibody Against Human CD137 And Use Thereof App 20180282422 - XU; Ting ; et al. | 2018-10-04 |
| Proteinaceous Heterodimer And Use Thereof App 20170340708 - XU; Ting ; et al. | 2017-11-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 